Loading clinical trials...
Loading clinical trials...
Behavioral Activation for Smoking Cessation in Veterans With PTSD
The purpose of this study is to examine whether behavioral activation as an adjuvant to standard smoking cessation treatment improves smoking cessation outcomes among veterans with PTSD relative to a comparably intense combination of standard smoking cessation treatment + health and smoking education. It is expected that behavioral activation will produce more successful results than health and smoking education when paired with standard smoking cessation treatment.
The purpose of this study is to examine whether behavioral activation as an adjuvant to standard smoking cessation treatment improves smoking cessation outcomes among veterans with PTSD relative to a comparably intense combination of standard smoking cessation treatment + health and smoking education. It is expected that behavioral activation will produce more successful results than health and smoking education when paired with standard smoking cessation treatment. After an initial phone screen, in-person screening, and baseline assessment, enrolled participants will be randomized to either behavioral activation therapy and standard smoking cessation treatment (BA+ST) or health and smoking education and standard smoking cessation treatment (HSE+ST). Both groups will meet with a therapist once a week for 8 weeks to receive either BA+ST or HSE+ST. Participants' mood and smoking outcomes will be monitored throughout the 8 weeks of treatment and at 2 follow-up visits and 2 follow-up phone calls.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
Yes
William S. Middleton Memorial Veterans Hospital, Madison, WI
Madison, Wisconsin, United States
Start Date
September 8, 2014
Primary Completion Date
March 29, 2019
Completion Date
March 29, 2019
Last Updated
April 15, 2020
124
ACTUAL participants
Behavioral Activation Therapy
BEHAVIORAL
Health and Smoking Education
BEHAVIORAL
Standard Smoking Cessation Therapy
BEHAVIORAL
Lead Sponsor
VA Office of Research and Development
Collaborators
NCT07010757
NCT07462312
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT07447089